Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Surgical Endoscopy
|
October 3, 2015
In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluation
Bertrand Napoleon, Anne-Isabelle Lemaistre, Bertrand Pujol, et al.
Brachytherapy
|
May 7, 2023
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments
Leonel Varela Cagetti, Laurence Moureau-Zabotto, Christophe Zemmour, et al.
Annals of Surgery
|
September 28, 2017
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study
Jean Robert Delpero, Florence Jeune, Philippe Bachellier, et al.
Annals of Gastroenterology
|
August 29, 2017
Impact of Full Spectrum Endoscopy® (Fuse®, EndoChoice®) on adenoma detection: a prospective French pilot study
Jean-Philippe Ratone, Erwan Bories, Fabrice Caillol, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
September 29, 2023
Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French Center
Jean-Philippe Ratone, Clément Archimbaud, Alexey Solovyev, et al.
Journal of Contemporary Brachytherapy
|
June 3, 2026
Chemoradiotherapy for anal canal cancers: Does the choice of boost technique matter?
Leonel Varela Cagetti, Julia Gilhodes, Marjorie Ferré, et al.
Cancer Research
|
May 20, 2016
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
Christine Pasero, Gwenaëlle Gravis, Mathilde Guerin, et al.
Oncotarget
|
April 29, 2017
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
Amira Mohamed, David Romano, Alexandru Saveanu, et al.
Npj Imaging
|
July 1, 2024
In vivo organoid growth monitoring by stimulated Raman histology
Barbara Sarri, Véronique Chevrier, Flora Poizat, et al.
Oncotarget
|
March 24, 2015
Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma
Maria Inés Molejon, Juan Ignacio Tellechea, Celine Loncle, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Surgical Endoscopy
|
October 3, 2015
In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluation
Bertrand Napoleon, Anne-Isabelle Lemaistre, Bertrand Pujol, et al.
Brachytherapy
|
May 7, 2023
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments
Leonel Varela Cagetti, Laurence Moureau-Zabotto, Christophe Zemmour, et al.
Annals of Surgery
|
September 28, 2017
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study
Jean Robert Delpero, Florence Jeune, Philippe Bachellier, et al.
Annals of Gastroenterology
|
August 29, 2017
Impact of Full Spectrum Endoscopy® (Fuse®, EndoChoice®) on adenoma detection: a prospective French pilot study
Jean-Philippe Ratone, Erwan Bories, Fabrice Caillol, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
September 29, 2023
Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French Center
Jean-Philippe Ratone, Clément Archimbaud, Alexey Solovyev, et al.
Journal of Contemporary Brachytherapy
|
June 3, 2026
Chemoradiotherapy for anal canal cancers: Does the choice of boost technique matter?
Leonel Varela Cagetti, Julia Gilhodes, Marjorie Ferré, et al.
Cancer Research
|
May 20, 2016
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
Christine Pasero, Gwenaëlle Gravis, Mathilde Guerin, et al.
Oncotarget
|
April 29, 2017
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
Amira Mohamed, David Romano, Alexandru Saveanu, et al.
Npj Imaging
|
July 1, 2024
In vivo organoid growth monitoring by stimulated Raman histology
Barbara Sarri, Véronique Chevrier, Flora Poizat, et al.
Oncotarget
|
March 24, 2015
Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma
Maria Inés Molejon, Juan Ignacio Tellechea, Celine Loncle, et al.
Page
of 9